Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Interferon Related Developmental Regulator 1 (IFRD1) Peptide

IFRD1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN978423

Quick Overview for Interferon Related Developmental Regulator 1 (IFRD1) Peptide (ABIN978423)

Target

IFRD1 (Interferon Related Developmental Regulator 1 (IFRD1))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Characteristics

    This is a synthetic peptide designed for use in combination with anti-IFRD1 antibody (Catalog #: ARP54585_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    IFRD1 (Interferon Related Developmental Regulator 1 (IFRD1))

    Background

    IFRD1 belongs to the IFRD family.It could play a role in regulating gene activity in the proliferative and/or differentiative pathways induced by NGF. IFRD1 may be an autocrine factor that attenuates or amplifies the initial ligand-induced signal.

    Alias Symbols: PC4, TIS7

    Protein Interaction Partner: HDAC2,RIT1,HDAC1,MYOD1,Sin3b

    Protein Size: 451

    Molecular Weight

    50 kDa

    Gene ID

    3475

    NCBI Accession

    NM_001550, NP_001541

    UniProt

    O00458
You are here:
Chat with us!